The global G-protein coupled receptors market size is expected to reach USD 4.36 billion by 2026 registering a CAGR of 6.7%, according to a new report by Grand View Research, Inc. Rising adoption of faster and accurate High-Throughput Screening (HTS) technology by pharmaceutical firms to develop potential G-protein coupled receptor-targeted therapeutics is expected to augment the market growth. HTS is used on the G-protein coupled receptor cell-based assays to assist several drug development programs.
Structural
and functional features of G-protein coupled receptors (GPCRs) allow it to
mediate physiological responses to hormones, stimulants, and neurotransmitters,
thus making them as potential therapeutic targets for various diseases. Recent
advancements in the structural biology of GPCRs have provided insights into the
molecular mechanisms of these receptors’ activation and activity. Several
pharmaceutical companies are undertaking efforts to develop G-protein coupled
receptors-targeted therapeutics for several disorders.
In
December 2018, Boehringer Ingelheim collaborated with Domain Therapeutics to
discover GPCR targets for the treatment of cancer, Central Nervous System
(CNS), and immunological disorders. Moreover, in May 2019, Evotec OAI AG
partnered with Euroscreen S.A. to improve its capabilities for GPCR targeting.
Evotec OAI will access GPCR reagents and AequoScreenTM technology of Euroscreen
for its drug discovery procedures. Such initiatives enhance the product
adoption as well as drug screening expertise in the pharmaceutical industry.
North
America is likely to be at the forefront of the market throughout the forecast
period due to heavy investments in cancer research to address the rising demand
for drug discovery and development procedures in U.S. Whereas, Asia Pacific is
expected to register the fastest CAGR over the forecast years. The region
witnesses a rising number of therapeutics development and contract research,
thus boosting G-protein coupled receptors market growth.
Full Research Report On G-Protein Coupled Receptors Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/g-protein-coupled-receptors-gpcrs-market
Further key
findings from the study suggest:
- Easy
availability of cell lines products and a large number of companies
offering a variety of cell lines resulted in the largest revenue share of
cell lines in 2018
- Increasing
usage of fully equipped detection kits instead of cell lines, reagents,
and ligands separately, marks the potential growth of detection kits in
the near future
- cAMP assays
serve as a versatile platform in HTS for explaining the GPCR functions,
which results in maximum revenue generation from these type of assays
- Cancer
research application accounted for the largest revenue share in 2018 owing
to increased number of cancer cases and investments in oncology R&D
- Ongoing
research studies to evaluate the pharmacology of GPCRs in chronic
inflammatory disorders reveals immense opportunities for research in
inflammatory applications
- Key companies
in the G-protein coupled receptor market include Perkin Elmer, Inc.;
Thermo Fisher Scientific; Eurofins Scientific; QIAGEN; Promega
Corporation; and Merck KGaA
- Acquisition,
partnerships, and collaborations are the major strategies adopted by these
companies to offer new GPCR-targeted medicines, thereby strengthening
their presence in the global GPCRs market
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/g-protein-coupled-receptors-gpcrs-market/request/rs1
Grand View Research has
segmented the global G-protein coupled receptors market on the basis product,
assay type, application, and region:
GPCRs Product
Outlook (Revenue, USD Million, 2015 - 2026)
- Cell Lines
- Detection Kits
- Cell Culture Reagents
- Ligands
GPCRs Assay Type
Outlook (Revenue, USD Million, 2015 - 2026)
- cAMP Functional Assays
- Calcium Functional Assays
- β-Arrestin Functional Assays
- Radioligand Binding and GTPγS Functional Assays
- Internalization Assays
- Trafficking Assays
- Other Assays
GPCRs Application
Outlook (Revenue, USD Million, 2015 - 2026)
- Cancer Research
- CNS Research
- Metabolic Research
- Cardiovascular Research
- Respiratory Research
- Inflammation Research
- Other Application
GPCRs Regional
Outlook (Revenue, USD Million, 2015 - 2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- China
- India
- Japan
- Latin America
- Brazil
- Middle East and Africa (MEA)
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment